AdaptHealth (NASDAQ:AHCO) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of AdaptHealth (NASDAQ:AHCO) from a buy rating to a strong-buy rating in a research report sent to investors on Sunday.

Several other equities research analysts have also issued reports on AHCO. Weiss Ratings reissued a “sell (d+)” rating on shares of AdaptHealth in a report on Wednesday, October 8th. Zacks Research lowered shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a report on Friday, September 19th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $13.40.

AdaptHealth Trading Up 0.1%

AdaptHealth stock opened at $9.14 on Friday. The firm has a 50 day moving average of $9.18 and a 200 day moving average of $9.00. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 16.93, a P/E/G ratio of 1.13 and a beta of 1.61. AdaptHealth has a 12-month low of $7.11 and a 12-month high of $11.63. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.14.

Insider Transactions at AdaptHealth

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares of the company’s stock, valued at $486,937.85. This trade represents a 14.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.55% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. GAMMA Investing LLC boosted its position in shares of AdaptHealth by 175.2% during the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock valued at $81,000 after acquiring an additional 4,758 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its position in shares of AdaptHealth by 6.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company’s stock valued at $356,000 after acquiring an additional 2,081 shares during the last quarter. New York State Teachers Retirement System boosted its position in shares of AdaptHealth by 3.3% during the 1st quarter. New York State Teachers Retirement System now owns 80,455 shares of the company’s stock valued at $872,000 after acquiring an additional 2,600 shares during the last quarter. Janney Montgomery Scott LLC bought a new position in shares of AdaptHealth during the 1st quarter valued at approximately $854,000. Finally, New York State Common Retirement Fund boosted its position in shares of AdaptHealth by 10.3% during the 1st quarter. New York State Common Retirement Fund now owns 836,773 shares of the company’s stock valued at $9,071,000 after acquiring an additional 78,211 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.